Showing results (1-10 of 204) with videos related to
Sort By:
Pageof 21
Journal of the National Comprehensive Cancer Network : JNCCN|May 22, 2015
Emerging treatment options for B-cell lymphomasAndrew D ZelenetzOncology (Williston Park, N.Y.)|December 20, 2003
Risk models for chemotherapy-induced neutropenia in non-Hodgkin's lymphomaAndrew D ZelenetzJournal of the National Comprehensive Cancer Network : JNCCN|November 26, 2019
The Era of Therapeutic Biosimilars Has Arrived: What You Need to KnowAndrew D ZelenetzSeminars in Oncology|May 3, 2003
A clinical and scientific overview of tositumomab and iodine I 131 tositumomabAndrew D ZelenetzJournal of the National Comprehensive Cancer Network : JNCCN|May 19, 2017
Chronic Lymphocytic Leukemia: Individualizing Treatment ApproachAndrew D ZelenetzJournal of the National Comprehensive Cancer Network : JNCCN|May 24, 2014
Guidelines for NHL: updates to the management of diffuse large B-cell lymphoma and new guidelines for primary cutaneous CD30+ T-cell lymphoproliferative disorders and T-cell large granular lymphocytic leukemiaAndrew D ZelenetzJournal of the National Comprehensive Cancer Network : JNCCN|May 24, 2014
International adaptation and use of NCCN GuidelinesAli Bazarbachi, Andrew D ZelenetzRadiologic Clinics of North America|July 16, 2008
Overview of lymphoma diagnosis and managementMatthew J Matasar, Andrew D ZelenetzJournal of the National Comprehensive Cancer Network : JNCCN|May 27, 2016
The Role of BiosimilarsAndrew D Zelenetz, Pamela S BeckerJournal of the National Comprehensive Cancer Network : JNCCN|May 25, 2013
Recent advances in the treatment of non-Hodgkin's lymphomasJeremy S Abramson, Andrew D ZelenetzPageof 21